Bowel Cancer News and Research

RSS

Bowel Cancer or colorectal cancer is cancer that occurs in the colon or rectum. Sometimes it is called colon cancer, for short. Colorectal cancer is the second leading cancer killer in the United States, but it doesn’t have to be.

Publication of death rates: an interview with Dr Kate Walker, London School of Hygiene and Tropical Medicine

The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England’s “Everyone Counts” policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.

15 Aug 2013

Metabolic fingerprinting accurately determines stages of bowel cancer

It is possible to see how advanced a bowel cancer is by looking at its metabolic 'fingerprint', according to new research.

13 Aug 2013

Western dietary pattern associated with increased risk of colorectal cancer

Fizzy drinks, cakes, biscuits, crisps and desserts have all been identified as risk factors for bowel cancer, according to new research.

16 Jul 2013

Research suggests that publication of death rates unlikely to detect poorly performing surgeons

New research published in The Lancet suggests that the publication of death rates for individual surgeons in England, launched for the first of a new group of 10 specialties last week, is unlikely to correctly identify poorly performing surgeons in some specialties, because low numbers of key operations lead to unreliable results.

9 Jul 2013

Mouse study identifies new treatment options for bowel cancer

Researchers have discovered the genetic processes that cause specific types of bowel cancer. Using this knowledge, they identified cancer drugs that target these genes. Their findings offer the opportunity to develop personalised treatment based on a person's genetic profile.

9 Jul 2013

New study could help increase survival rates of people with colorectal tumours

Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.

24 May 2013

Bowel cancer survival in the UK: an interview with Camille Maringe, London School of Hygiene and Tropical Medicine

Colorectal cancer is the third most common cancer in men and second in women, with over 1.2 million cases diagnosed worldwide in 2008.

14 May 2013

Low bowel cancer survival in the UK likely to be due to differences in staging and treatment

Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.

17 Apr 2013

Survival rate for bowel cancer patients lower in UK, new research finds

17 Apr 2013

Lynch syndrome and cancer risk: an interview with Prof. Ellen Kampman, Wageningen University

Lynch syndrome is one of the inherited cancer syndromes characterized by the development of colorectal cancer, endometrial cancer and other cancers at an early age.

10 Apr 2013

Eating your greens may be even more important than previously thought

Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.

5 Mar 2013

New method can determine seriousness of cancer prognosis with 80% certainty

The number of incorrect cancer prognoses can be halved with computerised image analysis. In three years time, the method can be used on patients with bowel cancer, ovarian cancer and prostate cancer.

6 Feb 2013

Colorectal cancer screening: an interview with Dr Donato F. Altomare

Colorectal cancer is a malignant neoplasm affecting the large bowel and the rectum mainly after the 5th decade of life and representing the second cause of death for cancer in western countries (the third in women). In about 15-20% of patients there is an inherited predisposition.

29 Jan 2013

New method may help predict response to chemotherapy for bowel cancer

Scientists at the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have developed a new method of predicting which patients with bowel (colorectal) cancer will respond effectively to chemotherapy. The results of this study are published in the current issue of the prestigious Cancer Research journal.

19 Jan 2013

mTorc1 promotes growth of inflammation-associated colon and gastric cancers

Researchers have identified a complex of proteins that promotes the growth of some types of colon and gastric cancers, and shown that medications that block the function of this complex have the potential to be developed into a new treatment for these diseases.

18 Jan 2013

Study finds relationships between body size and epigenetic changes

New research in human volunteers has shown that molecular changes to our genes, known as epigenetic marks, are driven mainly by ageing but are also affected by what we eat.

6 Dec 2012

Bowel cancer and GIST patients could benefit from novel oral drug

Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel (colorectal) cancer or gastrointestinal stromal tumour (GIST) following failure of existing treatments.

22 Nov 2012

Patients expect too much of screening and prevention

Patients overestimate the benefit that can be expected from cancer screening and preventive medications, setting minimal acceptable benefits unrealistically high, the results of a New Zealand study indicate.

15 Nov 2012

University of Sheffield scientists reveal secrets of DNA repair

Scientists from the University of Sheffield have unlocked one of the secrets to DNA repair -helping doctors identify DNA base damage and a patient's susceptibility to certain types of cancer.

1 Nov 2012

Physiologists, neuropathologists identify origin of cancer metastasis formation

It is not primary tumors that are responsible for the majority of cancer deaths, but rather their metastases. Physiologists and neuropathologists from the University of Zurich have now identified the origin of metastasis formation, thereby becoming the first to reveal the pathway of metastasizing intestinal cancer cells out of the blood stream. The results allow new approaches in the development of cancer therapies.

12 Jul 2012